Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nomin Javkhlan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JCI Insight|May 5, 2026
Pulmonary fibroblast subsets demonstrate differentially enriched signaling pathways during fibrosis resolution and repairDaniel G Foster, Nomin Javkhlan, Bart P Black, et al.
JCI Insight|February 8, 2023
Inhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosisJoseph C Cooley, Nomin Javkhlan, Jasmine A Wilson, et al.
American Journal of Respiratory Cell and Molecular Biology|May 6, 2026
Nintedanib increases BCL-2 in fibrotic fibroblasts enhancing ABT-199 apoptosis and fibrosis resolutionJoseph C Cooley, Sarah K Penick, Jasmine A Wilson, et al.
Nature Communications|March 1, 2026
Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 InhibitionElizabeth F Redente, Tengyao Song, Nomin Javkhlan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JCI Insight|May 5, 2026
Pulmonary fibroblast subsets demonstrate differentially enriched signaling pathways during fibrosis resolution and repairDaniel G Foster, Nomin Javkhlan, Bart P Black, et al.
JCI Insight|February 8, 2023
Inhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosisJoseph C Cooley, Nomin Javkhlan, Jasmine A Wilson, et al.
American Journal of Respiratory Cell and Molecular Biology|May 6, 2026
Nintedanib increases BCL-2 in fibrotic fibroblasts enhancing ABT-199 apoptosis and fibrosis resolutionJoseph C Cooley, Sarah K Penick, Jasmine A Wilson, et al.
Nature Communications|March 1, 2026
Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 InhibitionElizabeth F Redente, Tengyao Song, Nomin Javkhlan, et al.
Pageof 1